StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergen (AGN) PT Lowered to $181 at Raymond James
January 30, 2019 7:19 AM
Raymond James analyst Elliot Wilbur ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Credit Suisse Downgrades Allergen (AGN) to Neutral
January 31, 2019 4:56 AM
Allergen (AGN) PT Lowered to $200 at Mizuho Securities
January 30, 2019 8:21 AM
Allergen (AGN) PT Lowered to $229 at Guggenheim
January 30, 2019 7:13 AM
Allergen (AGN) PT Lowered to $199 at BofA/Merrill Lynch
January 30, 2019 6:10 AM
Morgan Stanley Downgrades Allergen (AGN) to Equalweight
January 30, 2019 5:06 AM
Allergen (AGN) PT Lowered to $161 at Piper Jaffray
January 30, 2019 4:35 AM
UPDATE: RBC Capital Downgrades Allergen (AGN) to Sector Perform; Not Delivering on Growth, Not Unlocking Value
January 30, 2019 12:02 AM
Pre-Open Stock Movers 01/29: (SANM) (DDD) (WWD) Higher; (GME) (HOG) (RMBS) Lower (more...)
January 29, 2019 9:16 AM
Allergan (AGN) in Final Stages of Selling Antibiotics Divisions, Plans to Keep Women's Health Unit - Bloomberg, Citing Conf. Call
January 29, 2019 8:43 AM
Form 8-K Allergan plc For: Jan 29
January 29, 2019 7:16 AM
Allergan (AGN) Tops Q4 EPS by 14c, Offers Q1 and FY Guidance, Approves $2B Buyback
January 29, 2019 7:04 AM
